2021 Reviewed Company Q2 30/06/2021 Unqualified opinion with an emphasis of matters /Others 2021 Reviewed Company Q1 31/03/2021 Unqualified opinion with an emphasis of matters /Others 2020
Q2 30/06/2021 Unqualified opinion with an emphasis of matters /Others 2021 Reviewed Company Q1 31/03/2021 Unqualified opinion with an emphasis of matters /Others 2020 Company Year 31/12/2020
Unqualified opinion with an emphasis of matters /Others 2020 Reviewed Consolidated Q2 30/06/2020 Unqualified opinion with an emphasis of matters /Others 2020 Reviewed Company Q1 31/03/2020 Unqualified
opinion 2020 Reviewed Company Q3 30/09/2020 2020 Reviewed Consolidated Q3 30/09/2020 2020 Reviewed Company Q2 30/06/2020 Unqualified opinion with an emphasis of matters /Others 2020
) (1,534.44) 511.79 33.35 Gross Profit (Loss) (65.56) 28.36 (93.92) (331.17) Sales & Administration Expenses and Financial Cost and Tax Expense (107.46) (108.80) (1.34) (1.23) Net Profit (Loss) (156.50) (72.32
) 1,230.51 274.45 Gross Profit (Loss) 163.14 (24.34) 187.48 770.25 Sales & Administration Expenses and Financial Cost and Tax Expense (32.44) (20.02) 12.42 62.04 Net Profit (Loss) 132.25 (43.62) 175.87 403.19
) causing the Center for COVID-19 Situation Administration (CCSA) to extend the period of the emergency decree further, together with the demand for biodiesel consumption is under the expectation after the
Statement MD&A Financial Statement Revise 2021 Company Year 31/12/2021 2021 Reviewed Company Q3 30/09/2021 2021 Reviewed Company Q2 30/06/2021 Unqualified opinion with an emphasis of matters
with an emphasis of matters /Others 2021 Reviewed Company Q1 31/03/2021 Unqualified opinion with an emphasis of matters /Others 2020 Company Year 31/12/2020 Unqualified opinion with an emphasis